DCF — ST ALEXIUS MEDICAL CENTER
Enterprise Value: $-204.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-204.7M
Enterprise Value
$-68.5M
PV of Cash Flows
$-136.2M
PV of Terminal Value
$-219.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $238.4M | $-10.7M | -4.0% | $-20.8M | $-18.9M |
| Year 2 | $245.5M | $-8.6M | -3.0% | $-19.0M | $-15.7M |
| Year 3 | $252.9M | $-6.3M | -2.0% | $-17.0M | $-12.8M |
| Year 4 | $260.5M | $-5.2M | -2.0% | $-16.2M | $-11.1M |
| Year 5 | $268.3M | $-4.7M | -2.0% | $-16.1M | $-10.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-204.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$231.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999805557738
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5